Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Cuba to Test New AIDS Vaccine on Humans

March 6, 2012

After showing initial promise, an AIDS vaccine candidate developed in Cuba will soon be ready for its first human clinical trial, researchers announced Monday at the International Biotech Conference-Havana 2012.

"The new AIDS trial vaccine already was tested successfully [on mice] and now we are preparing a very small, tightly controlled Phase I clinical trial" with HIV-positive patients whose disease is not advanced, Enrique Iglesias, head of the vaccine development team at the Biotech and Genetic Engineering Center (CIGB), told attendees of the Havana conference.

CIGB, which consists of about 20 research units on Havana's western end, is the engine behind a major export. Cuba annually ships out $400 million in biotechnology products like vaccines and other drugs; nickel is the nation's only bigger export.

The vaccine candidate, TERAVAC-HIV-1, is created with recombinant proteins and aims "to cause a cellular response against the virus," said Iglesias. However, he quickly downplayed expectations. "So far, there have been more than 100 clinical tests [on humans] with HIV" in Cuba and elsewhere to develop an AIDS vaccine, "and all of them have failed," he noted.

Some 600 researchers from about 38 countries are taking part in the conference.

Back to other news for March 2012

Adapted from:
Agence France Presse
03.06.2012


  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More News and Analysis on Vaccines for HIV Prevention

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement